Kendall Law Group Launches Pfizer Shareholder Investigation

DALLAS, Sept. 9, 2009 (GLOBE NEWSWIRE) -- Kendall Law Group, led by a former Federal Judge and former U.S. Attorney, launches a shareholder investigation into Pfizer (NYSE:PFE) for potential securities law violations on behalf of shareholders who purchased Pfizer stock from October 1, 2004 to January 23, 2009.

On September 2, 2009, Federal prosecutors hit Pfizer with a record-breaking $2.3 billion fine, including $1 billion in civil penalties and $100 million in criminal forfeiture. Authorities called the Company a repeat offender, as this is Pfizer's fourth settlement of government charges in the last decade. In fact, a Pfizer subsidiary, Pharmacia and Upjohn Inc. has entered an agreement to plead guilty to one count of felony misbranding. Between October 1, 2004 and January 23, 2009, Pfizer stock plummeted 51% from $28.50 to $14.58.

Although every case is different, Kendall Law Group has participated in the recovery of over $800 million for defrauded shareholders. Led by a former Federal Judge and former U.S. Attorney, the firm has the credentials to pursue any type of complex securities litigation in the nation. If you wish to serve as a plaintiff against the company for your stock loss or learn more about your rights as a shareholder, contact attorney Hamilton Lindley at 877-744-3728 or

The Kendall Law Group, LLP logo is available at


Contact Data